Welcome to the MDI website. Content and updating of information is ongoing on our website, therefore if you cannot find what you are looking for please contact us.

Board Member – Dr. Ashling Holland

Dr Ashling Holland

Dr Ashling Holland

Name
Dr. Ashling Holland

Current Position on Board
Director

Current Position/Job Title
Principal Scientist at PepGen Limited

Previous Position/Job Title
•             Senior Scientist, PepGen Limited (2018-2019)
•             Post-Doctoral Research Scientist, Oxford University (2017-2018)
•             Post-Doctoral Research Scientist, NUI Maynooth (2015-2017)

Current Membership of any Boards/Committees
•             MDI Board from 19/10/2020
•             MDI Research Committee from 19/10/2020

Previous Membership of any Boards/Committees

•             Post-Doc committee member, DPAG, University of Oxford, (2017-2018)
•             Athena SWAN committee member, DPAG, University of Oxford, (2017-2018)
•             MDEX Consortium member (2017-2018)
•             Chairperson of the Post-Grad/Post-Doc Committee, Biology Department, NUI Maynooth (2012-2016)
•             Treasurer Templeogue Basketball Club (2014-2016)
•             Student Treasurer of Galway Cycle (NUI Maynooth) (2014-2015)
•             Secretary of Galway Cycle (NUI Maynooth) (2013-2014)

Why I want to be on the Board of Muscular Dystrophy Ireland:
My scientific research over the past 10 years has primarily focused on muscular dystrophy. I was first introduced to MDI during my PhD as they sponsored some of my research endeavors. I presented my research at MDI’s 2015 AGM and was inspired by both the MDI team and community. Since then I have continued to work on MD research, both in Ireland and the UK. I would like to contribute to MDI’s mission of supporting people with MD. I believe that my international experience could help MDI develop and achieve its research and clinical goals.

What I bring to the Board of Muscular Dystrophy Ireland as a Director:
I have been working in muscular dystrophy research for the past decade, in both academic and private settings. I believe this, in addition to my experience in project management, successful project delivery, financial planning, goal setting, strategy development and my passion for helping to improve the lives of people with muscular dystrophy will be a benefit to MDI.

How I can help Muscular Dystrophy Ireland achieve its mission:
I believe I can help MDI achieve its mission of supporting people with muscular dystrophy by working closely with the board and the MDI community. I am a dedicated individual who has experience in identifying and prioritising long-term goals and future planning for organisations.

1. Muscular Dystrophies

  • Becker muscular dystrophy
  • Duchenne muscular dystrophy
  • Manifesting carrier of Duchenne
  • Congenital muscular dystrophy - General
  • • MDC1A (merosin-deficient congenital muscular dystrophy)
  • • Rigid spine syndrome (RSS)
  • • Ullrich congenital muscular dystrophies
  • • Bethlem myopathy
  • Emery-Dreifuss muscular dystrophy

2. Myotonic Disorders

  • Congenital Myotonic Dystrophy
  • Myotonia
  • Myotonic Dystrophy

3. Congenital Myopathies

  • Central Core Myopathy
  • Minicore (Multicore) myopathy
  • Myotubular or Centronuclear myopathy
  • Nemaline myopathy

4. Mitochondrial Myopathies

  • Mitochondrial Myopathies

5. Metabolic Disorders

  • Metabolic disorders (general)
  • McArdle’s Disease
  • Pompe’s Disease

6. Periodic Paralyses

  • Periodic Paralyses

7. Autoimmune Myositides

  • Polymyositis, Dermatomyositis and Sarcoid myopathy
  • Juvenile dermatomyositis
  • Inclusion body myositis

8. Spinal Muscular Atrophies

  • Severe (Type I)
  • Intermediate (Type II)
  • Mild (Type III)
  • Adult spinal muscular atrophy

9. Hereditary Motor and Sensory Neuropathies

  • (Also known as Charcot-Marie-Tooth or Peroneal muscular atrophy)

10. Disorders of the Neuromuscular Junction

  • Congenital myasthenic syndromes
  • Myasthenia Gravis

11. Friedreich’s Ataxia

  • Facioscapulohumeral muscular dystrophy
  • Limb-girdle types of muscular dystrophy (LGMD) - General
  • • LGMD 1B (also known as Laminopathy)
  • • LGMD 1C (also known as Caveolinopathy)
  • • LGMD 2A (also known as Calpainopathy)
  • • LGMD 2B (also known as Dysferlinopathy)
  • • LGMD 2I
  • Ocular myopathies including ocularopharangeal muscular dystrophy

12. Other (Please Specify)

13. Unspecified